Jane Street
TSHA icon

Jane Street’s Taysha Gene Therapies TSHA Stock Holding History

Jane Street’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,500
Closed -$60.3K – 13157
2026
Q1 		$60.3K Sell
13,500
-4,000
-23% -$18.6K ﹤0.01% 10896
2025
Q4 		$96.3K Buy
+17,500
New +$85K ﹤0.01% 10208
2023
Q4 		– Sell
-41,900
Closed -$132K – 9825
2023
Q3 		$132K Buy
+41,900
New +$78.3K ﹤0.01% 7846

Other funds holding TSHA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street's TSHA Position: Q2 2026 in Review

Jane Street opened a new position in Taysha Gene Therapies (TSHA) in Q2 2026: 228,355 shares worth $1.56M. The stake represents ﹤0.01% of the portfolio and ranks #5622 among its holdings. This is a return to the name: Jane Street previously reported a position in TSHA as recently as Q4 2025.

Jane Street first reported a position in TSHA in Q3 2020 and has held it in 10 quarters since. The position peaked at $1.82M in Q3 2025. 208 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Jane Street held 228,355 shares of Taysha Gene Therapies worth $1.56M as of Q2 2026.
  • Taysha Gene Therapies was a new Jane Street position in Q2 2026.
  • Taysha Gene Therapies made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5622 holding.
  • Jane Street first reported a position in Taysha Gene Therapies in Q3 2020 and has held it in 10 quarters since.
  • Jane Street's Taysha Gene Therapies position peaked at $1.82M in Q3 2025.
  • 208 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.